GENETIC FINAL
cancer
define = uncontrolled division of abnormal cells
apoptosis = PCD
maintain homeostasis
when damaged beyond repair, virus, stress, DNA damage
loss of apoptotic control can lead to cancer
apoptosis morphology
- discontinuous nuclear envelope
- condensation/shrink
- blebbing
- DNA fragmentation = karyorrhexis
- apoptotic bodies - phagocytosis
necrosis
- swelling
- smooth plasma membrane
- disintegration/membrane rupture
- cell lysis
cancer major changes
- immortalization
- transformation/proliferation
- angiogenesis
- metastasis
- evasion of apoptosis
- genetic instability
influential factors
- environment
- reproductive life
- lifestyle
- virus
- mutagenic
- defect in DNA replication
hallmarks
- evading growth suppressor
- avoiding immune destruction
- enabling replicative immortality
- tumor promoting inflammation
- activating invasion & metastasis
- inducing angiogenesis
- genome instability & mutation
- resisting cell death
- deregulating cellular energetics
- sustaining proliferative signaling
normal cells
- need external signals
- respond to inhibitory signals
- undergo apoptosis
- shorten telomere
- depend on blood vessel
- no metastasis
- cannot grow in low serum
- flat & extend
- anchorage dependence
- exhibit contact inhibition
cancer cells
- angiogenesis
- round
- anchorage dependence
- fail to exhibit contact inhibition
oncogene dominant gain of fx
proto oncogene (normal gene)
tumor suppressor gene recessive loss of fx
Knudson's: 2 recessive = carcinogenesis = recessive mutation
haploinsufficiency = 1 allele mutated = express cancer phenotype
metabolism
inborn errors of met AR or XR
carb:
PKD - PKLR 1q22
G6PD - XR
lactose intolerance - lactase, LCT
aa:
alkaptonuria - AR, homogentisate oxidase, HGD
PKU - phenylalanine hydroxylase, PAH
albinism - tyrosinase, no melanin, TYR/HPS/CH
maple syrup urine - AR, DBT
lipid:
Gaucher - glucocerebrosidase
Tay sac - beta hexosaminidase A
familial hypercholesterolemia - LDLR
urea:
hyperammonemia + arginase, argininosuccinate synthetase/lyase
congenital -
Type 1 - AR, carbamoyl phosphate synthetase
Type 2 - XR, ornithine transcarbamoylase
Type 3 - AR
N acetyl glutamate synthetase deficiency - low CPS 1
acquired
SAQ
Dr suhaili
1. many genetic ds disabling/fatal still common, will recessive allele which is lethal in homozygous condition completely removed from a large population? elaborate factor involved with ds example
no
presence of carrier
achromatopsia
Aa x Aa (AA is lethal)
50% carrier
pass genes to offspring
2. relationship between ... that are able to change allele fx of a genetic ds 3%
bottleneck effect = drastic reduction in population - reduce diversity - 天灾
founder effect = small group isolated from main population - reduce diversity - migration
genetic drift = change in allele frequency from gen to gen due to chance
natural selection = higher fitness higher survival
non random mating = choose partners based on specific traits
3. how are chromosome ds been diagnosed 2%
karyotyping, fluorescence in situ hybridization FISH
4. 2 approach looking at susceptible gene for complex ds 4% - strategies for cloning a ds gene
functional cloning - when know biochemical basis of ds - gene encode for enzyme/protein that deficient in disease
candidate gene - when able to guess what gene might be and test it directly in patients
positional cloning - when know disease gene's location in genome
5. write fully interpret reports for following 8%
a. 45, X/46, XX female recurrent miscarriage history
Turner syndrome with 45, X/46, XX mosaicism
b. 46, XX, del (14) (q23)
female with 46 chromosome with deletion on chromosome 14 long arm of band 23
c. 46, XY, dup (14) (q22q25)
male with 46 chromosome with duplication on chromosome 14 long arm of band 22 and 25
d. 46, XX, r (7) (p22q36)
female with 7 ring chromosome
the end of p arm of band 22 fuse with the end of q arm of band 36
6. allele frequency
p + q = 1
genotype frequency
p2 + 2pq + q2 = 1
f (WW)=p2=6/9=0.67
f (Ww)=2pq=1/9=0.11
f (ww)=q2=2/9=0.22
f (W)=p= (2(WW) + Ww)/2 (9) = 0.72
f (w)=q=0.28
Lod score
non recombinant: 8
recombinant: 2
recombinant factor = 2/10 = 0.2 = Θ
Z more than 3 = linked
Z less than -2 = not linked
Z = -2 ~ 3 need more data
genetic mapping - suhaili
3 types of map
- cytogenetic
- linkage
- physical
5 molecular markers
- restrictive fragments length polymorphism = southern blot
- amplified fragment length polymorphism = PCR technique
- minisatellites & microsatellites = STR/SSR & VNTR
- single nucleotide polymorphism = missense
- sequence tagged site
map molecular markers with linkage mapping & LOD mapping
human development
1 pre embryonic period 2w
2 embryonic period 3-8w
3 fetal period 9- ~37w
regional specification: different pattern from initial similar cell population - form several region
- gastrulation, neurulation, axis specification
growth: complex interplay of hormone, nutrient, genes
morphogenesis: change in cellular shape
cell differentiation: stem cell differentiate to differ fx
vs cell determination?
- gene
- signaling molecules
- CAM
- ECM
- cytoskeleton
holoprosencephaly: SHH, signaling molecules, growth - regional specification
achondroplasia/hypo, thanatophoric dysplasia : FGFR, signaling molecules, growth or morphogenesis
Duchenne muscular dystrophy: DMD, growth or morphogenesis
Alzheimer's/HTT, neuroblastoma, colon & small cell lung carcinoma: REST, zinc finger gene, differentiation
sympolydactyly: HOXD13, homeobox gene, morphogenesis
hand foot genital syndrome: HOXA13, homeobox gene
male sexual reversal (XY female): SOX9, HMG gene
define morphogen: 2%
substance that governs pattern of tissue development in morphogenesis
sonic hedgehog SHH
fibroblast growth factor FGF
Dr deming
factors contribute: 4%
lifestyle - nutrients switch on or off certain gene expression - obesity - healthy diet silent lipogenic gene
habits - smoking - damage DNA, promote tumor growth
socio economic
geographic location
define heritability: 6%
proportion of observed variability in a trait within a population attribute from genetic differences among these individuals
genetic contribution to multifactorial trait
how to study:
low (0.0) = environment factor
high (1.0) = genetic play role in trait
single gene ds
- clear family history
- early onset
- rare
- high accuracy for predict risk
- all cells
- germline mutation - embryonic stage
- cystic fibrosis
multifactorial ds
- long exposure to environmental factors
- common
- specific cells
- somatic cell mutation
- cancer
bioethics 2 question
values:
autonomy - patient has rights to refuse treatment
beneficence - practitioner should act in best interest of patient
non maleficence - "first, do no harm"
justice - for resource distribution, decision
dignity - way of treating patient & practitioner
truthfulness & honesty - informed consent required
why genetic interesting:
identify risk that not yet affect patient
about families as well as individuals
genetic research is commercially driven to a substantial degree
issue of genetic testing:
risk of being tested - psychological - bad gene positive: genetic determinism = possible overestimate of likelihood will suffer/become afflicted; negative: survivor guilt - overconfident no disease
public conceptions of genetics - beliefs - genetic determinism = idea of particular gene = particular trait
confidentiality & consent & duty to warn
commodifying genes - for commercialization - Myriad genetics holds patent on BRCA1&2 - insist only they can perform test for BRCA mutation
Comments
Post a Comment